Das Klinikum

Dr. med. Julia Sbierski-Kind

Dr. med. Julia Sbierski-Kind

Funktionsoberärztin

Arbeitsgruppenleiterin M3 Research Center

Kontakt

E-Mail-Adresse: julia.sbierski-kind@med.uni-tuebingen.de

Klinik / Institut / Zentrum

  • - innate immunity (innate lymphoid cells)
    - tissue biology
    - immunometabolism
    - gestational diabetes
    Students interested in an internship as part of their Bachelor's or Master's degree are always welcome. Interested candidates should send a CV and cover letter to julia.sbierski-kind@med.uni-tuebingen.de
  • 2006-2013Studium der Humanmedizin, Universität Freiburg; Auslandsaufenthalte in Grenoble (Frankreich), Zürich (Schweiz) und Buenos Aires (Argentinien)
  • 2013Dissertation und Approbation, Universitätsklinikum Freiburg
  • 01/2014-03/2019Weiterbildung im Fach Innere Medizin (Medizinische Klinik für Endokrinologie und Stoffwechselmedizin), Charité-Universitätsmedizin Berlin
  • 04/2019-05/2021Postdoctoral Research Fellow, Ari Molofsky Lab, Dept. of Laboratory Medicine, University of California, San Francisco, USA
  • 06/2021-12/2022Weiterbildung im Fach Innere Medizin (Medizinische Klinik und Poliklinik IV), LMU Klinikum, München
  • seit 01/2023Nachwuchsgruppenleiterin, M3 und Medizinische Fakultät und Ärztin, Medizinische Klinik IV - Diabetologie, Endokrinologie, Nephrologie
  • 03/2024Fachärztin für Innere Medizin und Endokrinologie und Diabetologie
  • 2016 Stipendium des Berlin Institute of Health Junior Clinican Scientist Program
  • 2018 BIH Paper of the Month: J. Sbierski-Kind, J. Kath, S. Brachs, M. Streitz, M.G. von Herrath, A.A. Kühl, K. Schmidt-Bleek, K. Mai, J. Spranger, and H.-D. Volk, Distinct Housing Conditions Reveal a Major Impact of Adaptive Immunity on the Course of Obesity-Induced Type 2 Diabetes. Front. Immunol. 9 (2018)
  • 2019 2-jähriges DFG Stipendium: „Die Typ 2-Immunantwort in der perivaskulären Nische im viszeralen Fetgewebe“
  • 2021 6-monatiges DFG-Rückkehrerstipendium
  • 2021 FöFoLe Anschubfinanzierung der Ludwig-Maximilians-Universität München
  • 2021 Stipendium Clinician Scientist Program der Deutschen Gesellschaft für Innere Medizin (DGIM)
  • 2022 Allgemeine Projektförderung der Deutschen Gesellschaft für Diabetologie (DDG)
  • 2022 Nachwuchsgruppenleiterstelle Medizinische Fakultät Tübingen
  • Auchynnikava V, Semeia L, Sippel K, Sbierski-Kind J, Fritsche A, Birkenfeld AL, Paluscke-Fröhlich J, Wikström AK, Preissl H; PREG study group. Fetal heart rate variability in relation to maternal physical activity and metabolic health. Early Hum Dev. 2025 May 1;206:106272. doi: 10.1016/j.earlhumdev.2025.106272
  • Ober V, Völk F, Sbierski-Kind J, Gruener E, Stirner R, Reiling G, Feldmann S, Ibarra G, Seybold U, Stubbe H, Adorjan K, Bogner JR, Roider J. Immune disturbances in individuals with post-COVID syndrome are not characterized by enhanced SARS-CoV-2-specific immunity. J Infect Dis. 2025 Apr 25:jiaf211. doi: 10.1093/infdis/jiaf211.
  • Sbierski-Kind J, Schlickeiser S, Semeia L, Harada S, Pappa E, Cujar JV, Katschke MT, Gar C, Lechner A, Birkenfeld AL, Ferrari U, Seissler J. Association of overweight/obesity and insulin resistance with activation of circulating innate lymphoid cells in women after gestational diabetes mellitus. Front Immunol. 2025 Mar 10;16:1559326. doi: 10.3389/fimmu.2025.1559326.
  • Lorza-Gil E, Strauss OD, Ziegler E, Kansy K, Katschke MT, Rahimi G, Neuscheler D, Sandforth L, Sandforth A, Sancar G, Kaufmann B, Hartmann D, Singer S, Mihaljevic AL, Jumpertz-von Schwartzenberg R, Sbierski-Kind J, Müller TD, Birkenfeld AL, Gerst F. Incretin-responsive human pancreatic adipose tissue organoids: A functional model for fatty pancreas research. Mol Metab. 2025 Jan;91:102067. doi: 10.1016/j.molmet.2024.102067.
  • Sbierski-Kind J, Schlickeiser S, Feldmann S, Ober V, Grüner E, Pleimelding C, Gilberg L, Brand I, Weigl N, Ahmed MIM, Ibarra G, Ruzicka M, Benesch C, Pernpruner A, Valdinoci E, Hoelscher M, Adorjan K, Stubbe HC, Pritsch M, Seybold U, Roider J; Post COVID Care and KoCo19 study groups. Persistent immune abnormalities discriminate post-COVID syndrome from convalescence. Infection. 2024 Jun;52(3):1087-1097. doi: 10.1007/s15010-023-02164-y
  • Group 2 innate lymphoid cells constrain type 3/17 lymphocytes in shared stromal niches to restrict liver fibrosis. Julia Sbierski-Kind, Kelly M Cautivo, Johanna C Wagner, Madelene W Dahlgren, Julia Nilsson, Maria Krasilnikov, Nicholas M. Mroz, Carlos O. Lizama, Anna Lu Gan, Peri R Matatia, Marcela T Taruselli, Anthony A Chang, Sofia Caryotakis, Claire E O’Leary, Maya Kotas, Aras N Mattis, Tien Peng, Richard M Locksley, Ari B Molofsky. bioRxiv 2023.04.26.537913; doi: https://doi.org/10.1101/2023.04.26.537913
  • Sbierski-Kind J, Grenkowitz S, Schlickeiser S, Koehn A, Friedrich M, Kunkel D, Glauben R, Brachs S, Mai K, Gordon J, Turnbaugh P, Volk HD, Spranger J, Jumpertz von Schwartzenberg J. Effects of caloric restriction on the gut microbiome are linked with immune senescence. Microbiome 2022 Apr
  • O'Leary CE, Sbierski-Kind J, Kotas ME, Wagner JC, Liang HE, Schroeder AW, de Tenorio JC, von Moltke J, Ricardo-Gonzalez RR, Eckalbar WL, Molofsky AB, Schneider C, Locksley RM. Bile acid-sensitive tuft cells regulate biliary neutrophil influx. Sci Immunol. 2022 Mar 4.
  • Cautivo KM, Matatia PR, Lizama CO, Mroz NM, Dahlgren MW, Yu X, Sbierski-Kind J, Taruselli MT, Brooks JF, Wade-Vallance A, Caryotakis SE, Chang AA, Liang HE, Zikherman J, Locksley RM, Molofsky AB. Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation. Immunity. 2022 Feb 8.
  • Sbierski-Kind J, Mroz N, Molofsky AB. Perivascular stromal cells: Directors of tissue immune niches. Immunol Rev. 2021 Jul.
  • Sbierski-Kind J, Goldeck D, Buchmann N, Spranger J, Volk HD, Steinhagen-Thiessen E, Pawelec G, Demuth I, Spira D. T cell phenotypes associated with insulin resistance: results from the Berlin Aging Study II. Immun Ageing. 2020 Dec 21.
  • Sbierski-Kind J, Mai K, Kath J, Jurisch A, Streitz M, Kuchenbecker L, Babel N, Nienen M, Jürchott K, Spranger L, Jumpertz von Schwartzenberg R, Decker AM, Krüger U, Volk HD, Spranger J. Association between Subcutaneous Adipose Tissue Inflammation, Insulin Resistance, and Calorie Restriction in Obese Females. J Immunol. 2020 Jul 1.
  • Sbierski-Kind J, Schmidt-Bleek K, Streitz M, Kath J, Spranger J, Volk HD. An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes. J Vis Exp. 2019 Apr 26
  • Sbierski-Kind J, Kath J, Brachs S, Streitz M, von Herrath MG, Kühl AA, Schmidt-Bleek K, Mai K, Spranger J, Volk HD. Distinct Housing Conditions Reveal a Major Impact of Adaptive Immunity on the Course of Obesity-Induced Type 2 Diabetes. Front Immunol. 2018 May 28.
  • Grahammer F, Wigge C, Schell C, Kretz O, Patrakka J, Schneider S, Klose M, Kind J, Arnold SJ, Habermann A, Bräuniger R, Rinschen MM, Völker L, Bregenzer A, Rubbenstroth D, Boerries M, Kerjaschki D, Miner JH, Walz G, Benzing T, Fornoni A, Frangakis AS, Huber TB. A flexible, multilayered protein scaffold maintains the slit in between glomerular podocytes. JCI Insight. 2016 Jun 16.